Alpha Arbutin vs Kojic Acid
Which is right for your skin?
Both fade dark spots by slowing melanin production. Alpha arbutin is the gentle, long-haul option built for sensitive skin and daily use; kojic acid is the more potent brightener for stubborn pigment but is likelier to irritate. Sensitive skin → arbutin; stubborn spots → kojic.
A safer, slower-acting alternative to prescription-strength dark-spot faders. Built for long-term use without irritation.
A brightening ingredient derived from fungi that fades dark spots and evens skin tone.
Can you use Alpha Arbutin and Kojic Acid together?
We have no documented layering conflict between Alpha Arbutin and Kojic Acid. Introduce one at a time and patch-test.
You want brightening. A safer, slower-acting alternative to prescription-strength dark-spot faders. Built for long-term use without irritation.
You want brightening. A brightening ingredient derived from fungi that fades dark spots and evens skin tone.
Cited research
Marziya M et al., Mechanism of Cyanotis arachnoidea Gel in improving melasma based on network pharmacology and transcriptomics, Zhongguo Zhong Yao Za Zhi (China Journal of Chinese Materia Medica) 2025;50(13):3775-3790 — Southwest Minzu University Chengdu; arbutin gel as positive-control comparator in melasma rat model
Sarkar R et al., Efficacy and Safety of a Topical Formulation Containing Trihydroxybenzoic Acid Glucoside and alpha-Arbutin in Indian Females With Facial Melasma, Journal of Cosmetic Dermatology 2025;24(2):e16753 — 120 Indian women: 10% THBG + 2% alpha-arbutin reduced melanin 16.3% and mMASI 18.4% with good tolerability
Ma ZY, Lu Y, Melanin synthesis and regulation in vivo and commonly used melanin inhibitors from natural products and traditional Chinese medicine, Zhongguo Zhong Yao Za Zhi (China Journal of Chinese Materia Medica) 2020;45(24):5898-5916 — Beijing University of Chinese Medicine review classifies arbutin among tyrosinase-active-site-targeting melanin inhibitors
MFDS Approved Functional Cosmetic Active — Alpha-Arbutin (whitening). Korean Ministry of Food and Drug Safety, Cosmetic Functional Active Ingredient List; authorized concentration documented in Jeon JS et al., Simultaneous determination of water-soluble whitening ingredients and adenosine in different cosmetic formulations, International Journal of Cosmetic Science 2016;38(3):286-93 (PMID:26564311) per the Korean Cosmetic Act and Functional Cosmetics Codex
Morag M et al., A double-blind, placebo-controlled randomized trial of Serratulae quinquefoliae folium, a new source of β-arbutin, in selected skin hyperpigmentations, Journal of Cosmetic Dermatology 2015 — 76% of melasma patients showed clinical lightening over 8 weeks
Dreher F et al., Efficacy of hydroquinone-free skin-lightening cream for photoaging, Journal of Cosmetic Dermatology 2013 — arbutin-containing hydroquinone-free formulation reduced mottled hyperpigmentation 32% at 12 weeks
Kim H, Choi HR, Kim DS, Park KC, Topical hypopigmenting agents for pigmentary disorders and their mechanisms of action, Annals of Dermatology 2012;24(1):1-6 — review classifies arbutin among hypopigmenting agents via tyrosinase regulation as a hydroquinone alternative
Seo DH et al., Biotechnological production of arbutins (alpha- and beta-arbutins), skin-lightening agents, and their derivatives, Applied Microbiology and Biotechnology 2012;95(6):1417-1425 — review documenting arbutin glycosylated hydroquinones as competitive tyrosinase inhibitors producing skin-whitening effect with improved safety vs hydroquinone
Ertam I et al., Efficiency of ellagic acid and arbutin in melasma: a randomized, prospective, open-label study, Journal of Dermatology 2008 — arbutin (and ellagic acid) formulations effectively reduced melasma severity
Tantanasrigul P et al., The Efficacy of Topical Cosmetic Containing Alpha-Arbutin 5% and Kojic Acid 2% Compared With Triple Combination Cream for the Treatment of Melasma: A Split-Face, Evaluator-Blinded Randomized Pilot Study, Journal of Cosmetic Dermatology 2025;24(1):e16562 — alpha-arbutin + kojic acid matched triple-combo cream with lower recurrence
Park JH et al., Evaluating the tolerance and efficacy of laser-assisted delivery of tranexamic acid, niacinamide, and kojic acid for melasma: A single center, prospective, split-face trial, Dermatologic Therapy 2022;35(3):e15287 — laser-assisted delivery of TXA/niacinamide/kojic acid produced greater melasma improvement vs laser alone
Zachary CB et al., Kojic Acid for Melasma: Popular Ingredient in Skincare Products, Skinmed 2020;18(5):271-273 — review of kojic acid's tyrosinase-inhibiting mechanism and clinical evidence as depigmenting topical for melasma
Miyabe C et al., Kojic acid alters pheomelanin content in human induced pluripotent stem cell-derived melanocytes, Journal of Dermatology 2020;47(4):435-436 — iPSC-derived melanocyte mechanism study: kojic acid alters pheomelanin composition, refining understanding of skin-lightening pathway beyond tyrosinase inhibition
Singh BK et al., Kojic Acid Peptide: A New Compound with Anti-Tyrosinase Potential, Annals of Dermatology 2016;28(5):555-561 — kojic acid peptide inhibits tyrosinase and reduces melanin without cytotoxicity, addressing the instability/toxicity limits of native kojic acid
Deo KS et al., Kojic acid vis-a-vis its combinations with hydroquinone and betamethasone valerate in melasma: a randomized, single blind, comparative study of efficacy and safety, Indian Journal of Dermatology 2013;58(4):281-5 — kojic acid + hydroquinone superior depigmenting agent over 12 weeks
Every entry points to a specific paper or regulatory document. See methodology for what each outcome label means.